title: Neonatal haemostasis and the management of neonatal thrombosis.
abstract: Two detailed reviews of the management of neonatal thrombosis were published in 2012; one was an up-dated version of guidance first issued in 2004 and the other was a comprehensive review. Both of these publications gave very similar advice regarding the practical aspects of the indications, dosage and management of antithrombotic therapy. The authors stated that the evidence supporting most of their recommendations for anti-thrombotic therapy in neonates remained weak and so the therapy for a neonate with a thrombosis has to be based on an individualized assessment of estimated risk versus potential benefit. The aim of this present review is to give the treating physician an outline of the unique physiology of neonatal coagulation and how this affects the monitoring, dosing and even the choice of therapeutic strategy for the management of thrombosis in the neonate.
authors.affiliation: Department of Paediatric Haematology, Royal Manchester Children's Hospital, Manchester, UK.
authors.forename: Andrew
authors.initials: A
authors.lastname: Will
mesh_terms: D019468:Disease Management; D006487:Hemostasis; D006801:Humans; D007231:Infant, Newborn; D013927:Thrombosis / Q000097:blood / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*
keywords: heparin; neonatal thrombosis; recombinant tissue plasminogen activator; thrombolysis; thrombophilia